Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of these medicinal products is substantial. |
Clinical Added Value
| no clinical added value |
PECFENT does not provide any improvement in actual benefit (IAB V) compared to rapid-acting morphine drugs indicated in the management of break through pain in adult patients who take morphine drugs to treat chronic cancer pain. |
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
p4wU9Ffp5pCrEgaZ
Listen
